Rosnano

Rosnano. A major Russian state-owned corporation established to develop the country's nanotechnology sector through direct investment and project financing. Founded in 2007 from the reorganization of the state-owned Russian Corporation of Nanotechnologies, it operates as a joint-stock company with the Government of Russia as its sole shareholder. The corporation's mandate has focused on commercializing advanced technologies and fostering a domestic high-tech industry, though its history has been marked by significant financial scrutiny and mixed results.

History

The entity was created by a decree from President Vladimir Putin in 2007, transforming the existing Russian Corporation of Nanotechnologies into a new form. Its establishment was part of a broader state initiative, championed by figures like Sergei Ivanov, to reduce the economy's dependence on hydrocarbon exports. The corporation's first leader was Anatoly Chubais, a prominent figure from the privatization era of the 1990s, who was appointed by Dmitry Medvedev. Early strategy involved creating a network of nanocenters across regions like Dubna and Tomsk, and making large-scale investments in areas such as solar energy and pharmaceuticals. The period following the 2014 Russian financial crisis saw increased pressure for profitability and a shift in some investment priorities.

Structure and management

The corporation is structured as a joint-stock company fully owned by the Government of Russia, with oversight from the Ministry of Industry and Trade. Its supervisory board has included high-profile individuals from government and industry, such as Andrey Belousov and German Gref. Day-to-day operations are managed by an executive board, which was led for over a decade by Anatoly Chubais until his resignation in 2020. The organization manages its investments through numerous subsidiary funds and project companies, often partnering with entities like Rusnano and the Skolkovo Foundation. Key operational divisions have focused on sectors including Microelectronics, composite materials, and Biotechnology.

Major projects and investments

The corporation's portfolio has spanned several high-tech domains, with significant capital allocated to the renewable energy sector. It financed the construction of photovoltaic panel manufacturing plants, partnering with companies like Hevel Solar. In healthcare, it invested in the production of generic pharmaceuticals and medical devices, including projects with Novartis. Other notable ventures included investments in LED lighting through Optogan, carbon fiber materials, and lithium-ion battery technology. Many projects were geographically dispersed, with significant hubs in Zelenograd, Saint Petersburg, and the Republic of Tatarstan.

Financial performance and controversies

Financial outcomes have been a persistent source of debate, with the corporation reporting substantial losses in several years, particularly following the devaluation of the ruble. Its investment model, which involved using significant state budget allocations and VEB.RF loans to fund high-risk tech startups, faced criticism from the Accounts Chamber and legislators in the State Duma. A major scandal emerged around the bankruptcy of the Svetlana electronics group, which had received considerable funding. The tenure of Anatoly Chubais was frequently scrutinized by media outlets like Kommersant and Novaya Gazeta, and investigations were occasionally referenced by Alexei Navalny. In 2020, the corporation underwent a major restructuring and debt reorganization with the assistance of VEB.RF.

See also

* Skolkovo Innovation Center * Russian Venture Company * National Technology Initiative * List of companies of Russia

Category:Companies established in 2007 Category:State-owned companies of Russia Category:Science and technology in Russia